Navigation Links
Pressure BioSciences, Inc. to Discuss 2007 Financial Results and Provide Business Update
Date:3/6/2008

SOUTH EASTON, Mass., March 6 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO) today announced that the Company will host a teleconference to discuss its 2007 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone or through a live web-cast. The teleconference and web-cast information is provided below:

Date: Wednesday March 12, 2008

Time: 4:30 p.m. Eastern Daylight Savings Time (EDST)

To attend this teleconference via web-cast, please go to the Company's website: http://www.pressurebiosciences.com

To attend this teleconference via telephone:

Dial-in: (800) 909-5202

Participant code: 4382794

For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call ends through April 4, 2008, and will be accessible through the Company's website. To access the replay, please dial (888) 203-1112 and enter passcode: 4382794.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a publicly-traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences' field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of chemical reactions, immunodiagnostics, and protein purification.

Investor Contacts:

R
'/>"/>

SOURCE Pressure BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
2. Pressure BioSciences, Inc. Issued First Patent in Canada
3. Interventional Cardiologists Nico Pijls, Bernard De Bruyne to Discuss Benefits of Measuring Coronary Pressure in Improving Multivessel PCI at ESC Congress 2007
4. Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320
5. Amgen and Genentech Brace Themselves for Heavy Pressure From Biogenerics Manufacturers
6. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
7. Pressure BioSciences, Inc. Provides Corporate Update
8. Results of Colon Cancer Study Utilizing Pressure Cycling Technology (PCT) Presented at the American College of Gastroenterology Annual Scientific Meeting
9. The sensitive side of carbon nanotubes: Creating powerful pressure sensors
10. FDA Approves Diovan(R) for Treatment of High Blood Pressure in Children
11. Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Palatin Technologies, In.... Patent and Trademark Office has issued U.S. Pate...de Constructs." The claims in the issued patent c...riuretic peptide receptor A (NPRA), including PL-3...,, "Our natriuretic compounds, including PL-399...
(Date:12/1/2009)... VANCOUVER, British Columbia, Dec. 1 /PRNewswire-F...subsidiary of The Dow Chemical Company (NYSE: DO...d the signing of a research and commercial license...Sciences with access to Agrisoma,s proprietary Eng...e basis in major food crops, and on a non-exclusiv...
(Date:12/1/2009)...ec. 1 /PRNewswire-FirstCall/ - BioSpec Global Solu...announced today that the company has contracted wi...for the manufacturing of the TOG,S 3000 and 9000(T...e have seen the disastrous results of food contami...salads in the past" said Don Saunders President an...
(Date:12/1/2009)...nical study presented to the American Society for ... (3-D) automated ultrasound follicle measurement u...ilization (IVF) cycle is effective and more effici...licles. , Gurnee, IL (PRW...ter of Chicago has just completed research on a ne...
Breaking Biology Technology:Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 3Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 2Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 3
...orporation,(Nasdaq: SIAL ), will hold its quarter...s on Wednesday, April 23, 2008, at 11:00 a.m. East...ing webcast by Thomson/CCBN and can be accessed at...drich.com ., The webcast is also being distribute... institutional and individual investors. Individua...
...Corporation (Nasdaq: BPUR ) announced today that ...ucts Regulatory Agency (MHRA) has found the,compan...eneral compliance,with the principles and guidelin...n the Commission Directives. The company received ... the issues classified as "Other" in,the MHRA,s or...
...all/ - ARIUS Research Inc., (TSX:,ARI), a biotechn...wave of,antibody therapeutics, today announced its...iscal quarter of 2008, ended February 29, 2008., ...ncing our antibody,drugs efficiently and rapidly t...we completed our pre-IND meeting with the US FDA f...
Other Biology Technology:Sigma-Aldrich Corporation 1st Quarter 2008 Earnings Conference Call 2Biopure Operations Compliant With U.K. Manufacturing Guidelines 2Biopure Operations Compliant With U.K. Manufacturing Guidelines 3ARIUS announces first quarter fiscal 2008 financial results 2ARIUS announces first quarter fiscal 2008 financial results 3ARIUS announces first quarter fiscal 2008 financial results 4ARIUS announces first quarter fiscal 2008 financial results 5ARIUS announces first quarter fiscal 2008 financial results 6ARIUS announces first quarter fiscal 2008 financial results 7ARIUS announces first quarter fiscal 2008 financial results 8ARIUS announces first quarter fiscal 2008 financial results 9ARIUS announces first quarter fiscal 2008 financial results 10ARIUS announces first quarter fiscal 2008 financial results 11ARIUS announces first quarter fiscal 2008 financial results 12
(Date:12/1/2009)...ss, like a bad cold, can spread among groups of pe...niversity of California-San Diego and Harvard show...tudy that has been following health conditions for... lonely people tend to share their loneliness with...isconnected people moves to the fringes of social ...
(Date:11/30/2009)...f scientists from The Forsyth Institute, the Unive...e Wadsworth Center, have used state-of-the-art tec... Treponema pallidum, the bacterium which causes sy...of the bacteria can now be shown in three dimensio...ogen and reveals previously unknown features, whic...
(Date:11/30/2009)...ors of The Journal of Experimental Biology are p...re National de la Recherche Scientifique (CNRS) in...ner of this year,s JEB Outstanding Paper Prize. ...ding achievement and is intended to encourage youn...or-in-Chief, and adds that ,we truly appreciate wh...
Breaking Biology News(10 mins):Loneliness can be contagious 2Loneliness can be contagious 3Scientists gain new understanding of disease-causing bacteria 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4MJFFs Rapid Response Innovation Awards Hit Mid 2009 With Over 241 Million Funded in High Risk High Reward Approaches to Parkinsons Disease 4652 1MJFFs Rapid Response Innovation Awards Hit Mid 2009 With Over 241 Million Funded in High Risk High Reward Approaches to Parkinsons Disease 4652 2MJFFs Rapid Response Innovation Awards Hit Mid 2009 With Over 241 Million Funded in High Risk High Reward Approaches to Parkinsons Disease 4652 3Structural biology scores with protein snapshot 9011 1Structural biology scores with protein snapshot 9011 2Structural biology scores with protein snapshot 9011 3Sanofi Pasteur Responds to Nations Need for Hib Vaccine With Increased Supply 12791 1Sanofi Pasteur Responds to Nations Need for Hib Vaccine With Increased Supply 12791 2Sanofi Pasteur Responds to Nations Need for Hib Vaccine With Increased Supply 12791 3Sanofi Pasteur Responds to Nations Need for Hib Vaccine With Increased Supply 12791 4Sanofi Pasteur Responds to Nations Need for Hib Vaccine With Increased Supply 12791 5Sanofi Pasteur Responds to Nations Need for Hib Vaccine With Increased Supply 12791 6
...normal heart rhythms arrhythmias are killers. Th...death, which accounts for about 10 percent of all ...tors have discovered a new molecular mechanism ass... in The Journal of Clinical Investigation , could...t antiarrhythmic drugs do not prolong life," said ...
...en three undergraduates set off on an expedition i...little did they realise that they were establishin...mate change. , New research led by the Universit...and found that, on average, species had moved uphi...o cope with changes in climate. , This is the fir...
...TI-Tecnalia, the technological centre specialising...international TXOTX (Technical eXperts Overseeing ...aim of this project is to collate the greatest inf...rograms from the different regions in the world,s ...and cooperation between countries, regional fisher...
Other Biology News:Studies point to novel target for treating arrhythmias 2Studies point to novel target for treating arrhythmias 3The global impact of climate change on biodiversity 2TXOTX, coordinated international project to contribute to sustainability of the marine resources 2
Mouse Anti-Human Vasopressin Monoclonal Antibody, Unconjugated, Clone VAS 2-10-8 from Meridian Life Science, Inc.
Mouse Anti-PCTAIRE 2 Monoclonal Antibody, Unconjugated, Clone 0.N.509 from Abcam
MMP-2/MMP-9 Inhibitor IV [SB-3CT] from CHEMICON
...ary high-performance desalting resin, exclusive to...tein-recovery characteristics compared to other co... low as 25 g/ml of protein can be processed, provi...ion of salts and other small molecules ( Exceptio...
Biology Products: